SurfWax News Index  |  Track News  |  Save/Exchange Information |  WikiWax |  About Us News and Articles on La Jolla Pharmaceutical (LJPC)   CBS Marketwatch Quote Chart Yahoo! Finance: Profile Key Statistics SEC Filings MSN Money Earnings Estimates Financial Results Insider Trading   Arena Pharmaceuticals posts loss, but improv...  Nov 10, 2009 La Jolla Pharmaceutical liquidation put on hold. La Jolla Pharmaceutical put off a vote on the liquidation of the company to Friday after it failed to receive enough proxy cards from shareholders supporting the move. (San Diego Union-Tribune) Benlysta Effective in Some Lupus Sufferers  Jul 20, 2009 In the past year a promising candidate from La Jolla Pharmaceutical () and BioMarin Pharmaceuticals () failed its clinical trial, as did Roche and Biogen Idec's () Rituxan, a drug already approved for other immune diseases. in failure, the seeds of success. (BusinessWeek) BioMarin returns rights to lupus drug  Apr 3, 2009 Novato s BioMarin (NASDAQ: BMRN) on Jan. 4 entered a development and commercialization deal with La Jolla Pharmaceutical (NASDAQ: LJPC). It paid the San Diego company $7. (San Francisco Business Times, CA) Where To Search For Rising Bargain Stocks During Tough Economic Conditions  Mar 28, 2009 MIAMI, FL, March 27 /PRNewswire/ - Today's Trade Alerts include: Cell Genesys Inc. (Nasdaq: ), La Jolla Pharmaceutical Company. (Nasdaq: ), Level 3 Communications (Nasdaq: ), Dryships Inc. (Nasdaq: ), Cell Genesys Inc. (Nasdaq: ). (PR Newswire) Back to Company News News [ Terms Of Use | Privacy | About ] ©1998-2006 SurfWax, Inc. All rights reserved. Patents pending. Copyright SurfWax, Inc. 2006